GCL
CNLM

Glazer Capital LLC’s CB PHARMA ACQUISISTION CORP SHS (CYM) CNLM Stock Holding History

Glazer Capital LLC’s Portfolio CNLM Stock Details CNLM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,824
Closed -$224K – 92
2015
Q4 		$224K Hold
21,824
– – 0.03% 62
2015
Q3 		$228K Hold
21,824
– – 0.03% 66
2015
Q2 		$230K Sell
21,824
-198,436
-90% -$1.95M 0.03% 58
2015
Q1 		$2.16M Buy
+220,260
New +$2.15M 0.33% 33

Other funds holding CNLM

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Glazer Capital LLC's CNLM Position: Q1 2016 in Review

Glazer Capital LLC sold out of CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) in Q1 2016, closing a stake of 21,824 shares — an estimated $224K sold.

Glazer Capital LLC first reported a position in CNLM in Q1 2015 and held it in 4 quarters. The position peaked at $2.16M in Q1 2015. 8 funds tracked by Wall St. Rank hold CNLM as of Q1 2016.

  • Glazer Capital LLC reported no remaining CB PHARMA ACQUISISTION CORP SHS (CYM) position as of Q1 2016 after selling out during the quarter.
  • Glazer Capital LLC sold 21,824 CB PHARMA ACQUISISTION CORP SHS (CYM) shares in Q1 2016, an estimated $224K.
  • Glazer Capital LLC first reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) in Q1 2015 and held it in 4 quarters.
  • Glazer Capital LLC's CB PHARMA ACQUISISTION CORP SHS (CYM) position peaked at $2.16M in Q1 2015.
  • 8 funds tracked by Wall St. Rank held CB PHARMA ACQUISISTION CORP SHS (CYM) as of Q1 2016.

Based on Glazer Capital LLC's 13F filing for Q1 2016, filed 13 May 2016.